Laser Photonics Completes Installation of Cutting-Edge Pill Drilling System at Customer Facility
Laser Photonics (NASDAQ: LASE) and its recently acquired subsidiary, Control Micro Systems, have completed the installation of a pill drilling system at a customer facility. The system, a Class I automated CO2 laser system, features custom tablet fixtures, fume extraction, and machine vision inspection for quality control. This installation aligns with LPC's new R&D initiative focusing on pharmaceuticals, wafers, and semiconductors sectors. The system serves as an anti-counterfeiting and pill drilling solution for the medical and pharmaceutical industry.
Laser Photonics (NASDAQ: LASE) e la sua recente acquisizione, Control Micro Systems, hanno completato l'installazione di un sistema per la perforazione di pillole presso un cliente. Il sistema, un sistema laser CO2 automatizzato di Classe I, dispone di supporti personalizzati per le compresse, estrazione dei fumi e ispezione visiva della macchina per il controllo qualità. Questa installazione è in linea con la nuova iniziativa di R&S di LPC, focalizzata sui settori farmaceutico, delle wafer e dei semiconduttori. Il sistema funge da soluzione anti-falsificazione e per la perforazione di pillole per l'industria medica e farmaceutica.
Laser Photonics (NASDAQ: LASE) y su filial recientemente adquirida, Control Micro Systems, han completado la instalación de un sistema de perforación de píldoras en las instalaciones de un cliente. El sistema, un sistema láser CO2 automatizado de Clase I, cuenta con dispositivos personalizados para tabletas, extracción de humos e inspección de visión por computadora para control de calidad. Esta instalación se alinea con la nueva iniciativa de I+D de LPC centrada en los sectores farmacéutico, de obleas y semiconductores. El sistema sirve como una solución contra la falsificación y de perforación de píldoras para la industria médica y farmacéutica.
Laser Photonics (NASDAQ: LASE)와 최근 인수한 자회사 Control Micro Systems가 고객 시설에 알약 천공 시스템 설치를 완료했습니다. 이 시스템은 맞춤형 알약 지지대, 연기 추출 및 품질 관리를 위한 머신 비전 검사가 포함된 1급 자동 CO2 레이저 시스템입니다. 이 설치는 제약, 웨이퍼 및 반도체 분야에 중점을 둔 LPC의 신규 연구개발 이니셔티브와 일치합니다. 이 시스템은 의료 및 제약 산업을 위한 항위조 및 알약 천공 솔루션 역할을 합니다.
Laser Photonics (NASDAQ: LASE) et sa filiale récemment acquise, Control Micro Systems, ont terminé l'installation d'un système de perçage de pilules dans les locaux d'un client. Le système, un système laser CO2 automatisé de Classe I, dispose de dispositifs adaptés aux comprimés, d'extraction de fumée et d'inspection par vision machine pour le contrôle de la qualité. Cette installation s'inscrit dans la nouvelle initiative de R&D de LPC axée sur les secteurs pharmaceutique, des plaquettes et des semi-conducteurs. Le système sert de solution anti-contrefaçon et de perçage de pilules pour l'industrie médicale et pharmaceutique.
Laser Photonics (NASDAQ: LASE) und die kürzlich erworbene Tochtergesellschaft Control Micro Systems haben die Installation eines Tablettbohrsystems in einer Kundenanlage abgeschlossen. Das System, ein automatisiertes CO2-Lasersystem der Klasse I, verfügt über maßgeschneiderte Tablettenhalterungen, Rauchabsaugung und Maschinenbildinspektion zur Qualitätskontrolle. Diese Installation entspricht LPCs neuer F&E-Initiative, die sich auf die Pharma-, Wafer- und Halbleitersektoren konzentriert. Das System dient als Anti-Fälschungs- und Tablettbohrlösung für die Medizin- und Pharmaindustrie.
- Successfully completed installation of new pill drilling system
- Expansion into pharmaceutical industry through Control Micro Systems acquisition
- Implementation of R&D initiative for new market sectors
- None.
Insights
The installation of the pill drilling system represents a meaningful step in LPC's expansion into pharmaceutical manufacturing technology. The system's key features - Class I automated CO2 laser, custom tablet fixture, fume extraction and machine vision inspection - position it well for anti-counterfeiting applications, a growing concern in pharmaceutical manufacturing.
The timing aligns strategically with LPC's R&D initiative targeting pharmaceuticals, wafers and semiconductors. This installation demonstrates practical market validation and revenue generation potential from the recent Control Micro Systems acquisition. The technology's focus on quality control and automation addresses critical needs in pharmaceutical manufacturing, where precision and consistency are paramount.
Following LPC's recent acquisition of Control Micro Systems, Inc., the two companies have shipped and installed one of their cutting-edge pill drilling systems. The installed product is a Class I automated CO2 laser system with a custom tablet fixture, fume extraction, and machine vision inspection for quality control. The laser system provides industry professionals with a consistent, effective and reliable laser drilling solution.
"This pill drilling system is an ideal anti-counterfeiting and pill drilling solution that we are proud to offer as a product through Control Micro Systems," said Wayne Tupuola, CEO of LPC. "With this innovative system, professionals in the medical and pharmaceutical industry can achieve the results they are looking for during the production of pills, tablets and capsules."
The system's installation follows LPC's recent announcement of a new R&D initiative that will focus on new sectors, including pharmaceuticals, wafers, and semiconductors. Through the R&D initiative the company will be devoting additional resources to advance its currently available technology to maintain a competitive edge and meet the market's needs. LPC's laser systems offer a sustainable solution for material processing in a wide variety of applications. For more information, visit the LPC website at www.laserphotonics.com.
About Laser Photonics Corporation
Laser Photonics is a vertically integrated manufacturer and R&D Center of Excellence for industrial laser technologies and systems. Laser Photonics seeks to disrupt the
Cautionary Note Concerning Forward-Looking Statements
This press release contains “forward-looking statements” (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), including statements regarding the Company’s plans, prospects, potential results and use of proceeds. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption “Risk Factors” in the Registration Statement. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241202131090/en/
Karla Kizzort
Marketing Specialist
Laser Photonics Corporation
kkizzort@laserphotonics.com
Source: Laser Photonics Corporation
FAQ
What type of laser system did Laser Photonics (LASE) install at the customer facility?
What are the new sectors Laser Photonics (LASE) is targeting through its R&D initiative?
What is the main purpose of Laser Photonics' (LASE) pill drilling system?
